Forecasts data is unavailable for this security.
Share price forecast
The 2 analysts offering 12 month price targets for Climb Bio Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a 27.48% increase from the last price of 3.53.
High | 41.6% | 5.00 |
Med | 27.5% | 4.50 |
Low | 13.3% | 4.00 |
Earnings history & estimates in USD
Average growth rate | +59.43% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼